Acute Myocardial Infarction in a Patient with Essential Thrombocythemia Treated with Glycoprotein IIb/IIIa Inhibitor
Clinical and Applied Thrombosis/Hemostasis, cilt.10, sa.1, ss.77-79, 2004 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 10 Sayı: 1
- Basım Tarihi: 2004
- Doi Numarası: 10.1177/107602960401000114
- Dergi Adı: Clinical and Applied Thrombosis/Hemostasis
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.77-79
- Anahtar Kelimeler: Acute myocardial infarction, Essential thrombocythemia, Glycoprotein IIb/IIIa receptor blocker, Tirofiban
- Trakya Üniversitesi Adresli: Evet
Özet
Essential thrombocythemia (ET) rarely causes obstruction of coronary arteries or acute myocardial infarction. Treatment of acute myocardial infarction in patients with ET may be a problem due to the important role of platelets in the pathogenesis of infarction. There is no reported case of acute myocardial infarction with essential thrombocythemia treated with a glycoprotein IIb/IIIa inhibitor. In this report, a 49-year-old woman with essential thrombocythemia, admitted with a diagnosis of acute inferolateral myocardial infarction, was treated with tirofiban, a glycoprotein IIb/IIIa receptor blocker.